Intec Closes Merger with Decoy Biosystems
Completes $30 Million Private Placement
Changes Corporate Name to Indaptus Therapeutics to Reflect Clinical Focus
NEW YORK, Aug. 3, 2021 /PRNewswire/ — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company,” and formerly, Intec Parent,…
